Source: Washington Monthly
by Nina Henry
“Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a power given it by the Inflation Reduction Act.” (10/23/24)
Source: Washington Monthly
by Nina Henry
“Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a power given it by the Inflation Reduction Act.” (10/23/24)